Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. [Phase 1]
Phase 1 clinical trial update assessing the safety and pharmacodynamics of QH103 cell injections in relapsed/refractory antibody-mediated ne…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healthy Volunteers
This clinical trial compares frailty, physical fitness parameters, and irisin levels between individuals with Multiple Sclerosis and healthy…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: My MS and My Menstrual Cycle
A University of Alberta clinical trial investigating the relationship between multiple sclerosis and the menstrual cycle has been suspended.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Multiple Sclerosis Falls Insight Track [NA]
This clinical trial update indicates a Multiple Sclerosis study is currently active but not recruiting participants.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab
This entry reports on a real-world study evaluating patient experience and satisfaction with ofatumumab for multiple sclerosis. The study is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis [Phase 3]
This clinical trial update describes ongoing Phase 3 efficacy and safety studies of Frexalimab (SAR441344) in adults with relapsing forms of…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Impact of Exercise Training on Serum Glial Fibrillary Acidic Protein (GFAP), Brain Volumetry, and Functional Outcomes in Multiple Sclerosis [NA]
This ClinicalTrials.gov entry describes a NOT_YET_RECRUITING study at Firat University assessing the effects of exercise training on serum G…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evaluation of the Effects of Laughter Yoga [NA]
A clinical trial evaluating the effects of laughter yoga in people with multiple sclerosis is currently recruiting at Firat University.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Walking Fatigability,Saptiotemporal Gait Parameters and Falling in MS Patients
A clinical trial investigating walking fatigability, spatiotemporal gait parameters, and falls in people with Multiple Sclerosis; the study …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis [Phase 1, Phase 2]
A Phase 1/2 clinical trial is assessing the safety and efficacy of Extracorporeal Photopheresis for Multiple Sclerosis, including Relapsing-…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
An update on an ongoing real-world study of intranasal MuSE exosomes and stem cells for neurological regenerative therapy, with enrollment b…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Effects of Stimulation Patterns of Deep Brain Stimulation [NA]
Clinical trial update on deep brain stimulation patterns for Parkinson disease and essential tremor, with potential relevance to multiple sc…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility
An update on a completed clinical study examining whether combined genetic and environmental risk scores influence susceptibility to multipl…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis [Phase 1]
Phase 1 clinical trial examining the safety, tolerability, and exploratory efficacy of IMS001 in adults with multiple sclerosis; the study i…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial update from Johns Hopkins evaluating glucagon-like peptide-1 receptor agonists for multiple sclerosis; the study is…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)
Biogen-sponsored study leveraging EU MS registry data to assess the incidence of anti-natalizumab antibodies in relapsing-remitting multiple…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Medication Understanding in MS
A University of Nottingham study titled 'Medication Understanding in MS' is listed for multiple sclerosis and is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
This clinical trial update summarizes the real-world experience of participants treated with BRIUMVI (ublituximab-xiiy) for Relapsing Multip…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: EXOPULSE Suit and Walking Ability of Patients With Multiple Sclerosis [NA]
This clinical trial investigates whether the EXOPULSE Suit improves walking ability in people with multiple sclerosis; the study is currentl…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS) [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating precision, biomarker-guided combination therapies for multiple sclerosis, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques [Phase 2]
This Phase 2 trial update describes a study sponsored by NINDS evaluating the effect of corticosteroids on inflammation at the edge of acute…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
This clinical trial update describes a study evaluating the effect of BRIUMVI (ublituximab) on pregnancy and infant outcomes in people with …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Effectiveness of TMS on Spasticity and Balance for Patients With MS [NA]
A clinical trial is evaluating the effectiveness of transcranial magnetic stimulation (TMS) on spasticity and balance in patients with multi…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update investigating hyperpolarized carbon metabolic imaging as a biomarker in multiple sclerosis, currently not yet …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis [NA]
This clinical trial investigates whether internal- or external-focused exercise training, performed together with a cognitive task, can impr…